Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ1H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,042
Award facts
- Contract value 100% obligated
- $24,041.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,041.74 delivery order to AmerisourceBergen Drug Corp for DUPIXENT (dupilumab) 300 mg/2 mL pen auto-injectors on January 15, 2026, with a completion date of January 16, 2026. This competitive, firm fixed-price contract includes no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999 and extends through December 2026, serving as the primary vehicle for supplying pharmaceuticals and medical supplies to military healthcare systems worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of its parent company, Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal government agencies including the Defense Health Agency and U.S. Coast Guard. The DUPIXENT delivery supports the Defense Logistics Agency's medical supply chain requirements, which provides critical medications across multiple therapeutic domains to military treatment facilities and veteran healthcare programs globally. The parent organization, Cencora, Inc., also maintains a separate $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical valued through December 31, 2031, further demonstrating the company's substantial role in federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DR26FJJ1H?
SPE2DR26FJJ1H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FJJ1H worth?
The government has obligated $24,042 on SPE2DR26FJJ1H.
Is contract SPE2DR26FJJ1H an order under another contract?
Yes. SPE2DR26FJJ1H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ1H competed?
The extent of competition for SPE2DR26FJJ1H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award